Real-world data show higher treatment persistence among patients using Wegovy compared with older weight-loss medications

Real-world data show many patients discontinue weight-loss medications within the first year

Expert Clinical Insights Metastatic Melanoma MEDICATION INSIGHTS: Lifileucel (Amtagvi™) The U.S. Food and Drug Administration (FDA) approved lifileucel (Amtagvi™) in February 2024 through the...

Only around one-third of patients prescribed weight loss drugs such as Novo Nordisk’s blockbuster injection Wegovy continued to take it a year later, according to an analysis shared with CNBC

As more and more high-cost therapies, including cell and gene therapies (CGTs), enter the U.S. market, commercial health plans have multiple tools at their disposal to manage these agents

cover image for 2026 Medical Pharmacy Trend Report: Part 1 - Payer Survey Packed with insights on real-world management trends for the hottest industry topics Prime Therapeutics...

Annual meeting will feature industry research posters and educational sessions

Abby Kim, PharmD, BCOP, is a senior director, clinical strategy and oncology specialty solutions, shares key takeaways from the American Journal of Managed Care (AJMC) forum, “Bridging evidence and...

Annual conference features presentations, panels, discussions and networking

Prerak Parikh represented Prime on a panel at Healthcare Advocate Summit 2025 in Las Vegas on Sept. 4 with other payer/PBM professionals